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Abstract
Background and Aim: Despite technological improvements in pancreatic surgery, the incidence and morbidity of
pancreatic leak after resection of distal pancreas are persistently high in most series. Laparoscopic distal pan-
createctomy (LDP) is today the gold standard procedure for benign and certain malignant neoplasms of the
pancreatic body and tail in specialized centers. This study evaluated safety and feasibility of a radiofrequency
(RF)-assisted transection device in a porcine model of LDP.
Materials and Methods: LDP was performed on 10 pigs (median weight, 39.6 kg) using a new device based on
an internally cooled RF-assisted electrode (Coolinside, Apeiron Medical, Valencia, Spain). The animals were
subjected to daily observation and then sacrificed and necropsied at 4 weeks postoperatively. Primary end
points were the development of postoperative pancreatic fistula using the Pancreatic Anastomotic Leak Study
Group definition and/or the presence of abdominal amylase-rich fluid collections or abscesses during necropsy
and pathological study and/or dye extravasation from the pancreatic remnant duct. Secondary end points were
intra- or postoperative complications, surgery, and transection duration.
Results: No clinically relevant postoperative pancreatic fistulas were observed. In one case a grade A post-
operative fistula was diagnosed due to amylase drain concentration of more than 6200 IU/mL on postoperative
day 4. Median peritoneal liquid amylase concentration on postoperative day 4 was 2399.0 IU/L (range, 819.2–
7122.0 IU/L), similar to the median plasma amylase level of 1520.8 IU/L (range, 1015.3–4056.6 IU/L). Median
surgery time was 93.5 minutes (range, 46.0–140.0 minutes), and median transection time was 4.5 minutes (range,
2.0–26.0 minutes). There was one postoperative wound infection. There were no postoperative deaths or major
complications. During the histopathological study, the surgical margin of the remaining pancreas showed a
common pattern with a central area of necrosis surrounded by granulomatous infiltrate and fibrosis. Ductal
obliteration was observed. No purulent inflammatory infiltrate or abscesses were present.
Conclusion: Experimental findings suggest that performing pancreatic transection with Coolinside in a animal
model of LDP is feasible and safe.
Introduction
Distal pancreatectomy (DP) with or without spleenpreservation has been applied with increasing frequency
in the management of a broad range of pancreatic pathologies
during the last two decades.1,2 Advances in operative tech-
nique and perioperative management have led to a substan-
tial decrease of postoperative mortality, achieving rates
between 0% and 6%.3,4 However, morbidity rates after this
procedure have not changed during the last 20 years, ranging
from 10% to 57% in larger series.1–4 Pancreatic fluid leak from
the pancreatic remnant and subsequent fistula formation have
been identified as the most frequent and serious post-DP
complications.5,6
Although laparoscopic DP (LDP) is safe and effective7–9
and is considered by some authors the best approach to
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left-sided pancreatic pathology in need of resection,8 no re-
duction in postoperative pancreatic fistula rates has been
demonstrated using this surgical approach in comparison
with the conventional open approach.8 The difficulty in pre-
venting pancreatic leak after DP has resulted in various
methods of closing the pancreatic stump. However, no
method has been clearly proven to be superior to others, as
reported in a recent meta-analysis.3,10,11
Radiofrequency (RF) energy-assisted devices have beenused
in both experimental and clinical surgery to manage sealing of
the pancreatic remnant after DP10,12 with initially encouraging
results in reducing postoperative pancreatic fistula.
In 2009 Burdio et al.13 reported their results in liver resec-
tion using a new RF-assisted device that was used to transect
hepatic tissue, to coagulate hepatic vessels up to 4mm in di-
ameter, and to seal bile ducts. Our hypothesis is that this RF-
assisted device, which has previously demonstrated a high
capability of closing resected tissues,13–16 could be suitable for
transecting pancreatic parenchyma and sealing the main and
secondary pancreatic ducts. The aim of this study was there-




The RF device is a laparoscopic version of the Coolinside
device (Apeiron Medical, Valencia, Spain). Its operating per-
formance has been described in detail elsewhere.15,16 In brief,
it consists of a handheld instrument that simultaneously
conducts the two surgical tasks of coagulation/sealing and
cutting. Coagulation and sealing are obtained from a 3-mm-
diameter electrode connected to an RF generator (model
CC-1, Radionics, Burlington, MA). The electrode is internally
cooled with chilled saline solution (0C) by means of a peri-
staltic pump (Radionics). Mechanical cutting is carried out by
a sharp blade attached distally to the electrode. The tissue is
coagulated by the proximal zone of the electrode with a
backward movement and is subsequently transected by the
blade, which cuts only the amount of tissue previously co-
agulated and sealed.15,16
Animals
Ten female Landrace pigs obtained from the farm of the
Universidad Autonoma of Barcelona (Barcelona, Spain) were
used for the experimental procedures. All aspects of this study
were performed as part of an animal research protocol ac-
cording to the guidelines approved by the Government of
Catalonia’s Animal Care Committee.
Preoperative care
Preoperative and anesthesia care was provided by fully
trained veterinary staff members. A combination of azaper-
one and ketamine (4mg/kg i.m. and 10mg/kg i.m., respec-
tively) was used for initial sedation. Intravenous access was
obtained by a marginal ear vein cannulation using large-
gauge venous catheters, and intravenous analgesia was given
before anesthesia (0.4mg/kg i.m. morphine and 0.2mg/kg
i.v. meloxicam).
Anesthetic induction was performed with propofol (4mg/
kg i.v.) and maintained with a mixture of isoflurane (1.5%–
2%) and oxygen (100%) once the animal was endotracheally
intubated.
Perioperative fluids consisted of Ringer’s solution at
10mL/kg/hour. Oxygen saturation and heart rate were
monitored using pulse oximetry placed on the ear.
The animals were secured supine on the operating table,
and sterile drapeswere applied after a betadine preparation of
the abdomen.
Surgical technique
All LDP procedures were performed by the same surgical
team using a four-port laparoscopic approach, following the
porcine model pancreatic dissection technique described
by Truty et al.10 After pancreatic dissection, approximately
4–6 cm of the distal pancreas was transected using the RF
device. The same device was used to seal and coagulate the
pancreatic remnant. The main pancreatic duct was neither
identified nor sutured after transection of the distal pancreas
in order to test the sealing efficacy of the RF device on the
pancreatic parenchyma. The resected specimen was then re-
moved through the umbilical orifice. A silicone drain was then
placed in the resection bed and brought out of the animal’s
abdomen through the 5-mm inferior right trocar orifice. The
proximal end was subcutaneously tunneled to the animal’s
back and connected to a reservoir. All wounds were closed in
standard fashion. The animals were allowed to awaken from
anesthesia and were extubated when clinically indicated.
Postoperative care
The animals were housed in large individual facilities at
our institution. Antibiotics (amoxicillin, 20mg/kg i.m., every
24 hours) were administered for the first 3 postoperative days.
All animals were given water ad libitum for the first 24 hours
and subsequently fed twice daily with pig chow thereafter.
All animals were inspected twice a day for the first 7
postoperative days in order to identify any suspicious clinical
sign of pancreatic leak or sepsis and to monitor debit and state
of abdominal drains. All animals received buprenorphine
(0.02–0.03mg/kg i.m., every 12 hours) for the first 24 post-
operative hours andmeloxicam (0.2mg/kg i.m., every 24 hours)
for postoperative analgesia on the first 3 postoperative days.
Necropsy
Four weeks after the initial procedure all animals were
again anesthetized, intubated, and ventilated as described
above. Exploratory laparotomy was performed, and the
peritoneal cavity was assessed for excessive adhesions or any
undrained fluid collections/abscess. The pancreatic stump
was identified, skeletonized, and photographed (Fig. 1). The
remnant pancreas (stump, uncinate process, and head) was
dissected, removed, and temporarily placed in 10% buffered
neutral formalin. Themain pancreatic duct was identified and
cannulated with an angiocatheter. A 1:5 dilution of Black
China dye was then injected into the pancreatic duct in a
retrograde fashion to assess for macroscopic dye extravasa-
tion from the pancreatic stump. Thereafter the specimen was
immersed in 10% buffered neutral formalin for further histo-
pathological processing.
The animals were then sacrificed with a commercial eu-
thanasia solution.
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Laboratory determinations
Serum amylase and glucose levels were obtained before
initial incision, 4 hours after intervention, and on postopera-
tive day 4 and 4 weeks postoperatively.
Peripancreatic fluid amylase levels were measured from
the drain tube on postoperative day 4. The drain tube was
retired between postoperative days 4 and 7.
Histopathologic study
Consecutive sections, 2mm thick, were obtained in the
margin of the interface of transection, including normal pan-
creas. Alternate sections were routinely processed, embedded
in paraffin, cut at a thickness of 5lm, stainedwith hematoxylin
and eosin, and evaluated by light microscopic examination.
Analyzed variables
The primary outcomes studied in our experiment were the
development of postoperative pancreatic leak defined as (1)
macroscopic leak (evidence of dye extravasation from the
pancreatic stump), (2) any undrained amylase-rich fluid col-
lections/abscess, and (3) greater than threefold drain/serum
amylase after the third postoperative day (the definition of a
biochemical leak according to the International Study Group
on Pancreatic Fistula guidelines6). Secondary outcomes were
operative time, transection time, intraoperative complica-
tions, wound infection, and other perioperative clinical pa-
rameters (anorexia, emesis, lethargy, and narcotic need).
Statistical analysis
Data are presented as median and minimum–maximum
value. Data collection and analyses were performed with
statistical software (SPSS version 16.0, SPSS, Inc., Chicago, IL).
Results
Therewere no deviations from the protocol described in the
methodology.
Animals
Median preoperative weight was 39.6 kg (range, 29.7–
74.0 kg). All animals increased their body weight during the
first postoperative month, with a median pre-necropsy
weight of 55.0 kg (range, 43.0–80.0 kg).
Biochemical determinations
Serum amylase and glucose levels throughout the study are
shown in Table 1.
It is of note that at the 4th postoperative hour, all animals
showed an increase in serum amylase levels, which returned
to levels similar to baseline on postoperative day 4.
Operative features
Median operative time was 93.5 minutes (range, 46.0–140.0
minutes), of which a median of 4.5 minutes (range, 2.0–26.0
minutes) was needed for pancreatic transection. No major in-
traoperative complications were observed. Superficial injuries
due to grasper manipulation were observed on gastric wall
serosa in 2 cases and repaired laparoscopically with suture on
both occasions. These animals showed no clinical or laboratory
complications during postoperative follow-up, and macro-
scopic examination during necropsy showed complete recov-
ery of gastricwall continuity. In 1 case, a superficial lesion of the
gastric serosa due to thermal injury during pancreatic tran-
section was observed, which did not affect the subserosal
muscular layer. Laparosocopic suture was performed, and the
animal did not present any postoperative clinical complication
or variation on necropsy findings. No thermal injuries or
complications related to the use of the device were otherwise
observed. There were no intraoperative deaths.
Postoperative follow-up
No animals showed lethargy, emesis, anorexia, or supple-
mentary narcotic need during the postoperative period. Only
FIG. 1. Macroscopic view of the remaining pancreas 4
weeks after performing laparoscopic distal pancreatectomy.
The black star indicates the distal pancreatic remnant. The
black arrow highlights fibroid tissue surrounding the trans-
ected surface of distal pancreas.
Table 1. Preoperative and Postoperative (4 Hours, 4 Days, and 4 Weeks Postoperatively)
Serum Amylase and Glucose Levels
Postoperative
Preoperative 4 hours 4 days 4 weeks
Serum amylase (IU/L) 1396.4 (1072.7–3003.8) 2201.9 (1179.1–3603.0) 1520.8 (1015.3–4056.0) 1356.0 (1048.0–2816.1)
Serum glucose (mg/dL) 117.4 (63.2–210.8) 122.1 (85.3–208.4) 115.0 (92.6–238.2) 100.8 (61.6–187.3)
Data are median (range) values.
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one trocar orifice infection was observed, which did not re-
quire surgical debridement or antibiotic treatment.
Necropsy
Neither dye extravasation from the pancreatic stump nor
any undrained amylase-rich fluid collections or abscesses
were observed in gross examination during necropsy. Thus,
no clinical or anatomic evidence of pancreatic fistula was
observed in any of the animals included in the study.
Amylase drain levels
Figure 2 shows the animals’ amylase concentration in drain
fluid on postoperative day 4. Postoperative measurement was
impossible in one animal because of drain loss on postopera-
tive day 1. Median peritoneal liquid amylase concentration
on postoperative day 4 was 2399.0 IU/L (range, 819.2–
7122.0 IU/L). As for biochemical pancreatic leak, using the
definition proposed by the International Study Group on
Pancreatic Fistula,6 a drain fluid amylase level of more than
threefold normal serum concentration on postoperative day 4
was only observed in one animal (7122.0 IU/L), which did not
present any postoperative clinical complication or free intra-
abdominal fluid during necropsy (Grade A fistula).
Histopathological study
The histopathological study of the transection margin of
the pancreas stump (Fig. 3) showed a common pattern with a
central area of coagulative necrosis surrounded by a granu-
lomatous inflammatory infiltrate, with macrophages and
multinucleated giant cells. An intense fibrosis was present,
delimiting the necrotic material and the inflammatory infil-
trate. The fibrosis reaction completely encircled the main and
secundary pancreatic ducts located at the margin of normal
pancreas. Scattered infiltrate of lymphocytes, plasma cells,
and eosinophils were seen in the fibrous boundary. No pu-
rulent inflammatory infiltrate or abscesses were observed in
any sample.
Discussion
The results of this experimental study suggest that per-
forming pancreatic transection with the Coolinside device in
an LDP animal model could be feasible and safe.
Morbidity after DP is still a challenging problem, with
postoperative rates ranging from 10% to 57% in high-volume
centers.1–6,17,18 Pancreatic fistula is a main cause of postop-
erative complications and is associated with numerous fur-
ther problems, such as intraabdominal abscesses, wound
infection, sepsis, electrolyte imbalance, malabsorption, and
hemorrhage and with a dramatic increase in healthcare re-
source utilization.3,17
Several surgical resection and closure techniques have been
introduced for DP in an attempt to reduce complications, es-
pecially pancreatic fistulas.17 Unfortunately, none of these
has shown a clear superiority3 as reported in a recent meta-
analysis in which no significant differences were found
between stitch suture and stapler closure in relation to pan-
creatic fistula or intraabdominal abscess rates (31.2% and
22.1% rates of postoperative pancreatic leak, respectively).19
In our study, we hypothesized that RF energy could have
an obliterative effect on pancreatic ductal structures, as has
previously been demonstrated for vascular and biliary
structures.16 Furthermore, as the RF device used in the present
study had previously been proven to be able to seal vessels up
to 4mm in diameter,16 we decided to test its capacity to seal
the main pancreatic duct without previous identification and
ligation. Our findings on the histopathological examination of
the pancreatic remnants 4 weeks after transection confirmed
our hypothesis because they showed a common pattern of
progressive obliteration of both main and secondary pancre-
atic ducts (see Fig. 3).
We agree with Truty et al.10 that simple main duct ligation
and traditional oversewing of the gland with sutures does not
completely seal the small pancreatic ducts, leading to persis-
tent extravasation of enzyme-rich pancreatic fluid, and that
the porcine model is an excellent approximation to the human
pancreas,10 with its ‘‘soft’’ texture making it a good model for
high-risk pancreatic leak.1,10,20 We can speculate that this risk
is in part increased by the crushing of the pancreatic tissue and
the consequent destruction of small pancreatic ducts due to
the pressure applied by a mechanical stapler before cutting
and staple application.11 In our model no pressure is applied
to the pancreatic tissue, and only the previously sealed pa-
renchyma are then cut by the device, thus avoiding the rup-
ture of small pancreatic ducts before sealing.
At gross examination during necropsy, all animals showed
the same pattern of minimal postoperative field adhesions,
without inflammatory signs, free peritoneal liquids, or ab-
scesses (see Fig. 2). The transection surface of the pancreatic
stump presented a thick fibrous surface of more than 1mm
(see Fig. 3). Under this fibrotic ‘‘envelope,’’ a common pattern
of sterile coagulative necrosis was found in all specimens,
with no signs of necrosis of the pancreatic remnant. No signs
of pancreatitis were found on microscopical analysis of the
pancreatic remnant, indicating that the coagulative necrosis
achieved with RF application does not increase the risk of
pancreatic inflammatory reaction, as has been observed by
other authors.10
This conclusion was confirmed by the absence of clinical
signs of pancreatitis and biochemical elevation of serum am-
ylase during postoperative follow-up. No signs were found of
the intense pyogranulomatous inflammatory reaction caused
by silk suture or of a pattern of peristaple serpentine necrosis
due to intermittent crushing of tissue along the staple line, as
is caused by mechanical suture.11
FIG. 2. Drain amylase concentration at postoperative
day 4.
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In our opinion the coagulative necrosis of the transected
surface caused by thermal injury and the consequent reactive
fibrosis could provide a stronger ‘‘defense’’ against pancreatic
fluid leak compared with the inflammatory reaction to silk
and staplers, and the absence of foreign bodies could decrease
the risk of microorganism colonization. A comparative study
is needed to confirm our hypothesis.
Another important issue in our study was to evaluate the
handling of the Coolinside during LPD. The diffusion of
laparoscopic surgery of distal pancreas and the need for
simple and ergonomic methods to manage the pancreatic
stump during this surgical approach are probably the main
reasons for the increasing interest in finding a simple and
effective method to cut and seal the pancreatic remnant.3,7 At
present, no single instrument adequately addresses simulta-
neously transection, hemostasis, and sealing of pancreatic
ducts. The vast majority of pancreatic parenchymal transec-
tions are performed using at least two different instruments,7
which involves greater complexity and time-consuming,
costly operations.
Our attention was focused on testing the capacity of a
single device able to cut and seal the pancreatic tissue without
increasing surgical complexity or requiring additional time.
Previous comparative experimental studies had shown that
the use of the Coolinside device alone for both laparoscopic
transection and sealing of liver tissue decreased surgical time
and blood loss.16
In this studywe found no technical difficulty in performing
laparoscopic transection with the Coolinside device, as can be
seen from the median surgical and resection times. The ability
to perform laparoscopic pancreatic transection with no need
to identify or suture the main pancreatic duct is certainly the
device’s main advantage, provided that future studies con-
firm the low postoperative fistula rates suggested in this
feasibility study. The device seems to be very easy to use and
permits the sealing of pancreatic ducts and coagulation of
FIG. 3. Transection margin of
the pancreas (hematoxylin and
eosin stain). (A) Complete his-
tological section showing the
area of coagulative necrosis
(asterisk) surrounded by fibro-
sis. (B) Fibrosis band (arrow)
between the necrosis area and
the normal pancreas, sur-
rounding the main pancreatic
duct (arrowhead). (C) Interface
between necrosis and neo-
formed connective tissue, with
macrophages and giant cells.
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small pancreatic vessels before the blade cuts the previously
coagulated tissue. These preliminary results suggest that
this device could provide good hemostasis of both pancre-
atic tissue and surrounding fat tissue and avoid the need for
other coagulating devices during and after pancreatic resec-
tion. No intraoperative hemorrhages were observed during
our study.
Nomajor complicationswere found associatedwith the use
of the device, and only one clinically insignificant superficial
gastric lesion could be attributed to thermal injury to nearby
structures.
Study limitations
Our study has certain limitations, which should be pointed
out. The most important is related to the sample size, which
was too small to confirm the efficacy of the Coolinside device
to prevent postoperative pancreatic leak. In spite of this lim-
itation, the absence of clinical andmacroscopic pancreatic leak
is encouraging (only one animal presented a biochemical
Grade A pancreatic fistula on the grading scheme of the In-
ternational Study Group on Pancreatic Fistula).
Certain anatomic differences between pigs and humans
limit the model’s applicability to pancreatic surgery.11 First,
the tail of the pancreas is far more intraperitoneal in pigs than
in humans, making LDP significantly less challenging in the
pig. Second, as most researchers do,11 we used as surgical
models young pigs, which have little intra- and peripancreatic
fat, which could limit the applicability of our results to hu-
mans. On the other hand, as stated before, the possibility of
performing pancreatic transection and sealing using only one
device without the need for main duct identification and li-
gation seems to make further research on its feasibility for use
on humans worthwhile.
Conclusions
Preliminary results suggest that performing pancreatic
transection and sealing with the Coolinside device during
LDP is feasible and safe. Based on our results, comparative
studies and human trials are needed to assess the clinical
utility of this device.
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